Naloxone Hydrochloride Injection, Solution
Product Images NDC 51662-1586

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 51662-1586). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ser 1 (51662 1586 1 Serialized Labeling)

NALOXONE HYDROCHLORIDE Injection, USP carton label showing dosage strength of 2 mg per 2 mL (1 mg/mL) solution for injection. The label indicates the product is intended for intramuscular, intravenous, or subcutaneous use. The labeler is HF Acquisition Co LLC, DBA HealthFirst, and the product NDC is visible on the carton.*

FDA Label Image

Pouch Labeling (51662 1586 2 Pouch Labeling)

Label for Naloxone Hydrochloride Injection, USP, 2 mg per 2 mL (1 mg/mL) solution. The label includes NDC 51662-1586-2, lot number, expiration date, and directions indicating use as an opioid antagonist for intravenous, intramuscular, or subcutaneous injection. It notes storage conditions, no latex in the stopper, and manufacturer HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*

FDA Label Image

Case (51662 1586 3 Case Labeling)

NALOXONE HYDROCHLORIDE Injection, USP label for 2 mg per 2 mL (1 mg/mL) solution in a 2 mL syringe, case of 10. The label indicates intramuscular, intravenous, and subcutaneous routes, with instructions and storage conditions. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA. Includes lot number, expiration date, and a QR code.*

FDA Label Image

Rfid (51662 1586 3 Rfid Serialized Case Labeling)

NALOXONE HYDROCHLORIDE 1 mg/mL injection solution label showing the NDC 51662-1586 barcode and unique product identifiers. The label indicates it is distributed by HF Acquisition Co LLC, DBA HealthFirst, with directions to refer to the manufacturer’s package insert. The label is marked RX ONLY.*

FDA Label Image

Box 1 (Box Label 1)

Box label for Naloxone Hydrochloride Injection, USP 1 mg/mL in 2 mg per 2 mL (single-dose prefilled syringe). The label indicates use for intravenous, intramuscular, or subcutaneous injection by Auromedics Pharma LLC, distributed by HF Acquisition Co LLC, DBA HealthFirst. The package includes directions for use and storage conditions.*

FDA Label Image

Box 2 (Box Label 2)

Packaging label for Naloxone Hydrochloride Injection, USP, 1 mg/mL (2 mg per 2 mL) in a single-dose disposable prefilled syringe. The label indicates use for intravenous, intramuscular, and subcutaneous injection. Distributed by Auromedics Pharma LLC, the package includes administration instructions and cautions, with NDC 55150-345-01.*

FDA Label Image

Instructions (Instructions)

Instructional images demonstrating the assembly and preparation of a syringe with plunger rod for injection. The images show removing the syringe and plunger rod from packaging, inserting and twisting the plunger rod, holding the syringe upright, removing the tip cap, and expelling air before administering the injection. Text instructions also note intravenous, intramuscular, or subcutaneous routes and pressing the plunger rod to administer the drug.*

FDA Label Image

Structure (Structure)

Chemical structure of Naloxone Hydrochloride showing its molecular framework and chemical name as (-)-17-Allyl-4, 5a-epoxy-3, 14-dihydroxy morphinan-6-one hydrochloride.*

FDA Label Image

S2 (Syringe Label 2)

Label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) in a single dose disposable prefilled syringe. The injectable solution is for intravenous, intramuscular, or subcutaneous use. Distributed by AuroMedics Pharma LLC and made in India. Includes storage instructions and dosage note.*

FDA Label Image

S1 (Syringe Label)

Label for Naloxone Hydrochloride Injection, USP 2 mg per 2 mL (1 mg/mL) solution in a single dose disposable prefilled syringe. The injection is for intravenous, intramuscular, or subcutaneous use. Distributed by AuroMedics Pharma LLC, made in India, with instructions to protect from light, store at 20° to 25°C, and include regulatory and ingredient details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.